3.43
price up icon0.88%   0.03
after-market Handel nachbörslich: 3.43
loading

Cosciens Biopharma Inc Aktie (CSCI) Neueste Nachrichten

pulisher
Jun 10, 2025

TSX:CSCI Forum Post | prophetoffactz-36604398 | PGX-YBG | COSCIENS Biopharma Inc - Stockhouse

Jun 10, 2025
pulisher
Jun 09, 2025

COSCIENS Biopharma reports on forward-looking statements By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

COSCIENS Biopharma Announces Virtual Shareholder Meeting on June 30, 2025 - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

COSCIENS Biopharma reports on forward-looking statements - Investing.com

Jun 09, 2025
pulisher
Jun 06, 2025

AEZSAeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders - mx.advfn.com

Jun 06, 2025
pulisher
Jun 01, 2025

COSCIENS Biopharma reconstitutes board - MSN

Jun 01, 2025
pulisher
May 30, 2025

COSCIENS BiopharmaEnters Resolution Agreement With Goodwood, Goodwood Fund, And Puccetti Funds Management - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

COSCIENS Biopharma Schedules Virtual Annual Meeting for June 30, 2025 - TipRanks

May 30, 2025
pulisher
May 30, 2025

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Share - GuruFocus

May 30, 2025
pulisher
May 30, 2025

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders | CSCI Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Cosciens Biopharma Brief: Entering Into a Resolution Agreement With Goodwood Inc. As Co Reconstitutes Board for Benefit of Shareholders - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders - The Manila Times

May 30, 2025
pulisher
May 30, 2025

COSCIENS Biopharma Overhauls Board with Pharma Veterans After 8.2% Stakeholder Agreement - Stock Titan

May 30, 2025
pulisher
May 27, 2025

Cosciens Biopharma announces receipt of Goodwood intended director nominations - Yahoo Finance

May 27, 2025
pulisher
May 27, 2025

COSCIENS Biopharma Receives Director Nominations Ahead of Shareholder Meeting - TipRanks

May 27, 2025
pulisher
May 26, 2025

COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Directo - GuruFocus

May 26, 2025
pulisher
May 26, 2025

COSCIENS Biopharma Receives Director Nominations from Goodwood - TipRanks

May 26, 2025
pulisher
May 26, 2025

COSCIENS Biopharma Inc. Acknowledges Director Nominations from Goodwood Fund Ahead of Annual Shareholder Meeting - Nasdaq

May 26, 2025
pulisher
May 26, 2025

COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders - The Manila Times

May 26, 2025
pulisher
May 26, 2025

Cosciens Biopharma Brief: Acknowledging Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders - marketscreener.com

May 26, 2025
pulisher
May 26, 2025

Activist Investor Goodwood Nominates 6 Directors to COSCIENS Board | CSCI Stock News - Stock Titan

May 26, 2025
pulisher
May 24, 2025

Goodwood Seeks Board Overhaul At Cosciens Biopharma - Finimize

May 24, 2025
pulisher
May 23, 2025

Goodwood to Nominate New Directors for COSCIENS Biopharma Inc. - The Globe and Mail

May 23, 2025
pulisher
May 22, 2025

Goodwood To Nominate New Directors For COSCIENS Biopharma Inc. - Barchart.com

May 22, 2025
pulisher
May 22, 2025

Databricks Announces 2025 Data + AI Summit Keynote Lineup and Data Intelligence Programming - The Globe and Mail

May 22, 2025
pulisher
May 20, 2025

COSCIENS Biopharma Reports Q1 2025 Results and Updates - TipRanks

May 20, 2025
pulisher
May 20, 2025

COSCIENS Biopharma reports key corporate updates By Investing.com - Investing.com India

May 20, 2025
pulisher
May 20, 2025

COSCIENS Biopharma reports key corporate updates - Investing.com

May 20, 2025
pulisher
May 20, 2025

COSCIENS Biopharma Completes Merger with Ceapro and Restructures Governance - TipRanks

May 20, 2025
pulisher
May 18, 2025

Waverley Pharma: Top 10 Undervalued Biotechnology Industry Stocks (WAVE) - The Globe and Mail

May 18, 2025
pulisher
May 14, 2025

COSCIENS Biopharma: Q1 Earnings Snapshot - CT Insider

May 14, 2025
pulisher
May 13, 2025

COSCIENS Biopharma reports Q1 2025 results, updates strategy By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Res - GuruFocus

May 13, 2025
pulisher
May 13, 2025

COSCIENS Biopharma reports Q1 2025 results, updates strategy - Investing.com

May 13, 2025
pulisher
May 13, 2025

COSCIENS Biopharma Reports Q1 2025 Results and Strategic Updates - TipRanks

May 13, 2025
pulisher
May 13, 2025

COSCIENS Biopharma Reports Q1 2025 Financial Results Amid Strategic Shifts - TipRanks

May 13, 2025
pulisher
May 13, 2025

Cosciens Biopharma Brief: Appointing Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Cosciens Biopharma Brief: Company Says Ended Quarter with US$13.8 Million in Cash - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Cosciens Biopharma Brief: Reported a Q1 Consolidated Net Loss of US$3.7 Million, or $1.16 Loss Per Common Share - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

COSCIENS Biopharma Inc. Transitions to Pure-Play Natural Products Company, Announces Phase 2 Clinical Trial Advancements and New CEO Appointment - Nasdaq

May 13, 2025
pulisher
May 13, 2025

COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

COSCIENS Earnings Reveal Strategic Pivot to Natural Products While Advancing Key Clinical Trial - Stock Titan

May 13, 2025
pulisher
May 05, 2025

COSCIENS Biopharma Inc. Reports Transformative Year - TipRanks

May 05, 2025
pulisher
May 02, 2025

COSCIENS Biopharma Sets Date for Annual Meeting Amid Strategic Shifts - TipRanks

May 02, 2025
pulisher
Apr 20, 2025

Fennec Pharmaceuticals: Top 10 Undervalued Biotechnology Industry Stocks (FRX) - The Globe and Mail

Apr 20, 2025
pulisher
Apr 18, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Apr 18, 2025
pulisher
Apr 15, 2025

COSCIENS Biopharma appoints Anna Biehn as new CEO amid leadership change - N24.com.tr

Apr 15, 2025
pulisher
Apr 15, 2025

COSCIENS Biopharma Inc. Appoints Global Consumer Products and Bi - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

COSCIENS Biopharma (CSCI) Names Anna Biehn as New CEO | CSCI Sto - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

COSCIENS Biopharma names new CEO Anna Biehn By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

COSCIENS Biopharma names new CEO Anna Biehn - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

COSCIENS Biopharma names Anna Biehn as new CEO By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

COSCIENS Biopharma Full Year 2024 Earnings: US$5.93 loss per share (vs US$1.89 loss in FY 2023) - simplywall.st

Apr 14, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):